Ex Vivo Intravascular Ultrasound Assessment of Transcatheter Valve Deformation in Bicuspid Anatomy Authors: Karol A Sadowski, Michał Kania, Jarosław Kuriata, Jacek Kądziela, Łukasz Kalińczuk, Ole De Backer Published: 2026 ABSTRACT AbstractBackgroundTranscatheter heart valve (THV) deployment in severely calcified bicuspid aortic valve (BAV) can result in complex frame deformation. Large field-of-view intravascular ultrasound (IVUS) offers a tomographic real-time assessment of this phenomenon.Case SummaryA 53-year-old male underwent surgery for severe calcific BAV stenosis. Ex vivo, a 26-mm Evolut THV was deployed inside the excised BAV specimen without balloon predilatation or postdilatation to preserve native calcified constraints. Automated IVUS pullback with a 10-MHz IVUS (Visions PV .035, Philips) over a 0.035-inch guidewire revealed severe inflow constraint (41.2% expansion) but preserved expansion at the leaflet nadir (107.6%) and coaptation (104.5%) levels.DiscussionWhile recent clinical computed tomography studies report THV frame decoupling, real-time procedural imaging remains limited. This case provides direct mechanistic proof of how a rigid calcified raphe causes this segmental deformation.Take-Home MessagesIVUS demonstrated inflow-to-functional-frame decoupling. Severe inflow constraint may coexist with preserved supra-annular leaflet-level expansion.Key words: BAV, IVUS, THV IVUS Demonstration of Evolut THV Stent-Frame Decoupling in Calcified Bicuspid Anatomy (A) Ex vivo THV deployment and IVUS model. The study was conducted in an aquarium with water maintained at 36.6 °C. The BAV specimen was immobilized using a third-hand tool. A large field-of-view 10-MHz IVUS catheter (Visions PV .035, Philips) was advanced manually and withdrawn using an automatic pullback. (B) Excised native BAV specimen and matched IVUS images. En face view of the native BAV cusps specimen and matched IVUS image at the orifice (cusps) level. Measured GOA dimensions include Dmin, Dmax, and CSA. (C) Evolut THV stent-frame deformation: caliper–IVUS agreement across matched levels. BAV specimen after Evolut THV implantation with corresponding IVUS cross-sections at inflow, leaflet nadir, and coaptation levels. IVUS-derived dimensions showed close agreement with direct ex vivo digital caliper measurements, supporting accurate tomographic quantification of actual THV frame geometry. IVUS confirmed the phenomenon of inflow-to-functional-frame decoupling: The rigid calcified raphe severely constrains the inflow portion, while the supra-annular functional leaflet portion remains relatively preserved. BAV = bicuspid aortic valve; CSA = cross-sectional area; GOA = geometric orifice area; IVUS = intravascular ultrasound; THV = transcatheter heart valve. Background Severe calcific bicuspid aortic valve (BAV) anatomy, particularly a rigid calcified raphe and asymmetric cusp fusion, may constrain self-expanding transcatheter heart valve (THV) frames, causing nonuniform underexpansion and eccentricity.1 Large field-of-view intravascular ultrasound (IVUS) using contemporary 0.035-inch peripheral systems provides a periprocedural tomographic method for direct assessment of actual THV frame geometry. Prior reports have demonstrated the feasibility of IVUS-guided assessment during transcatheter valve procedures, including aortic, pulmonary, mitral, and tricuspid interventions.2,3 Take-Home Messages •Large field-of-view intravascular ultrasound (Visions PV .035, Philips) provides real-time tomographic visualization of actual transcatheter heart valve frame deformation, clearly demonstrating the phenomenon of inflow-to-functional-frame decoupling in challenging calcified bicuspid aortic valve anatomy. Large field-of-view intravascular ultrasound (Visions PV .035, Philips) provides real-time tomographic visualization of actual transcatheter heart valve frame deformation, clearly demonstrating the phenomenon of inflow-to-functional-frame decoupling in challenging calcified bicuspid aortic valve anatomy. •A rigid calcified bicuspid raphe can severely constrain the inflow portion of a self-expanding Evolut transcatheter heart valve (Medtronic), yet this severe inflow underexpansion may coexist with relative preservation of the supra-annular leaflet-bearing frame. A rigid calcified bicuspid raphe can severely constrain the inflow portion of a self-expanding Evolut transcatheter heart valve (Medtronic), yet this severe inflow underexpansion may coexist with relative preservation of the supra-annular leaflet-bearing frame. Here, we present a surgically excised stenotic BAV specimen examined ex vivo with 10-MHz large field-of-view IVUS (Visions PV .035, Philips) before and after deployment of a self-expanding supra-annular Evolut THV (Medtronic), demonstrating matched-level assessment of inflow constraint, ellipticity, and supra-annular functional-frame preservation. Case Summary The surgically excised BAV specimen was obtained from a 53-year-old male undergoing surgical aortic valve replacement for severe calcific BAV disease with concomitant aortic regurgitation and ascending aortic dilatation. Preoperative transthoracic echocardiography showed severe aortic stenosis, with peak/mean gradients of 91/54 mm Hg, aortic valve area approximately 0.9 to 1.0 cm2, moderate aortic regurgitation, preserved left ventricular ejection fraction, and ascending aortic dilatation. Preoperative angiography-computed tomography (angio-CT) confirmed right–left coronary cusp fusion, markedly thickened and calcified leaflets, and an aortic valve calcium score of 6,100 Agatston units. The sinus measured 42 × 42 × 34 mm, the sinotubular junction (STJ) 32 × 34 mm, and the ascending aorta up to 46 mm. The baseline angio-CT assessment demonstrated bulky calcification of the fused cusp–raphe complex and marked restriction of the geometric orifice area (GOA), providing an anatomic link between the clinical CT, the surgically excised specimen, and the ex vivo IVUS findings (Figure 1). The specimen was immobilized in warmed water at 36.6 °C, and a 10-MHz IVUS catheter (Visions PV .035, Philips), with a 60-mm field of view and 0.035-inch guidewire compatibility, was manually advanced and withdrawn using an automated pullback system (Figure 2). At the native BAV orifice level, IVUS delineated the eccentric residual orifice and bulky calcified raphe, with dimensions closely matching direct ex vivo measurements (Figure 3). A 26-mm Evolut was selected for this mechanistic model, not as a conventional clinical CT annular-sizing recommendation. Although angio-CT showed large annular and supra-annular dimensions—left ventricular outflow tract 27.5 × 34.7 mm, annulus 29.4 × 34.5 mm, intercommissural distance (ICD) 31.7 mm, and STJ 32.1 × 36.8 mm—the functional GOA was markedly restricted and eccentric, measuring 11.9 × 22.5 mm, with an area of 144 mm2. Because the maximal GOA diameter of 22.5 mm falls within the 20- to 23-mm annular diameter range listed for the 26-mm Evolut platform, the 26-mm valve was chosen as a pragmatic orifice-constraint-based ex vivo test device. The THV was deployed with its inflow positioned at the specimen GOA—cusp-margin level, without balloon predilatation or postdilatation, deliberately preserving the native rigid calcified constraint. Automated IVUS pullback was performed using a 10-MHz large field-of-view IVUS catheter advanced over a 0.035-inch guidewire positioned through the THV. Actual Evolut THV stent-frame geometry was quantified at matched inflow, leaflet nadir, and coaptation levels using both digital calipers and IVUS to measure minimal and maximal inner diameters (Dmin and Dmax) and inner cross-sectional area (CSA). Percentage expansion was calculated as actual/nominal CSA × 100%, and ellipticity as Dmax/Dmin. At the inflow level, the frame was severely constrained, with Dmin and Dmax of 14.0 × 18.8 mm, CSA 203 mm2, 41.2% frame expansion, and ellipticity 1.34. At the leaflet nadir and coaptation levels, geometry was relatively preserved: 19.8 × 23.0 mm and 20.6 × 23.7 mm, respectively, with 107.6% and 104.5% expansion (Figure 4). Figure 5 provides a visual representation of nonuniform frame deformation across the 7 stent-frame nodes, based on IVUS measurements. Baseline Angio-CT Assessment of the Calcified BAV, Showing: LVOT, Annulus, ICD, GOA, and STJ LVOT and annular dimensions include Dmin, Dmax, and CSA. The GOA panel shows the restricted eccentric bicuspid orifice, calcified commissure, and bulky calcified raphe. BAV = bicuspid aortic valve; CSA = cross-sectional area; CT = computed tomography; GOA = geometric orifice area; ICD = intercommissural distance; LVOT = left ventricular outflow tract; STJ = sinotubular junction. Ex vivo THV Deployment and IVUS Model The study was conducted in an aquarium with water maintained at 36.6 °C. The BAV specimen was immobilized using a third-hand tool. A large field-of-view 10-MHz IVUS catheter (Visions PV .035, Philips) was advanced manually and withdrawn using an automatic pullback. IVUS = intravascular ultrasound; THV = transcatheter heart valve. Excised Native BAV Specimen and Matched IVUS Images (A) En face view of the native BAV cusps specimen and (B) matched IVUS image at the cusp/orifice level. Measured GOA dimensions include: Dmin, Dmax, and CSA. ∗indicates the IVUS probe. BAV = bicuspid aortic valve; CSA = cross-sectional area; GOA = geometric orifice area; IVUS = intravascular ultrasound. Evolut THV Stent-Frame Deformation: Caliper–IVUS Agreement Across Matched Levels BAV specimen after Evolut THV implantation with corresponding IVUS cross-sections at inflow, leaflet nadir, and coaptation levels. IVUS-derived Dmin, Dmax, and CSA showed close agreement with direct ex vivo digital caliper measurements, supporting accurate tomographic quantification of actual THV frame geometry. CSA = cross-sectional area; IVUS = intravascular ultrasound; THV = transcatheter heart valve. Indexes of Evolut Transcatheter Heart Valve Stent-Frame Expansion and Ellipticity Presented Across the 7 Stent-Frame Nodes Limitations and Interpretive Cautions This single ex vivo model lacked physiologic flow, gradients, leaflet motion, thrombosis assessment, and clinical outcome data. Balloon predilatation and postdilatation were intentionally omitted to preserve the native calcified BAV constraint although this differs from routine clinical THV replacement. Therefore, the observed underexpansion reflects a deliberately severe experimental condition rather than an optimized clinical result. The findings should be interpreted as mechanistic proof-of-principle and do not define thresholds for valve selection, dilatation, or procedural acceptance. Prospective in vivo validation integrating IVUS, CT, hemodynamics, and clinical follow-up is required. Conclusions This ex vivo report demonstrates that large field-of-view IVUS can directly visualize and quantify self-expanding THV frame deformation in a severely calcified BAV specimen. The dominant finding was profound constraint of the inflow frame by the rigid fused leaflet–raphe complex, with relative preservation of the supra-annular functional leaflet-bearing portion of the frame. Baseline angio-CT demonstrated markedly asymmetric bicuspid anatomy, with bulky calcification involving the fused leaflet–raphe complex. This rigid calcified structure provided an anatomic explanation for the severe constraint of the THV inflow observed after ex vivo deployment, while allowing relative preservation of the supra-annular functional portion of the frame. This spatial dissociation is consistent with the previously described inflow-to-functional-frame decoupling behavior of self-expanding supra-annular THVs. In a recent in vivo CT study of THV stent-frame expansion in BAVs, the inflow level of the Evolut THV showed greater underexpansion than the leaflet level (79.9% ± 6.7% vs 95.4% ± 3.1%; P < 0.001) and greater ellipticity (1.3 ± 0.3 vs 1.2 ± 0.1; P < 0.001). Leaflet-level expansion was not determined by inflow expansion or ellipticity, although leaflet-level ellipticity increased when inflow expansion was <75% or inflow ellipticity was ≥1.3. Importantly, neither inflow underexpansion nor ellipticity affected short-term hemodynamic valve performance or leaflet thickening.1 Our findings extend this concept to an intentionally extreme ex vivo setting, showing that severe inflow constraint may coexist with preservation of the supra-annular functional frame, with apparent frame decoupling and actual relative stent-frame overexpansion at the coaptation level (Figure 6).4 However, the observed inflow expansion of approximately 40% to 50% should not be considered an acceptable clinical deployment endpoint. Previously Published Bench Image Adapted With Permission and Annotated to Show Matched Transcatheter Heart Valve Stent-Frame Levels A 26-mm CoreValve deployed in a 21-mm orifice in a supra-annular position demonstrates inflow constriction with relatively greater mid-frame expansion, illustrating nonuniform self-expanding frame deformation and inflow-to-functional-frame decoupling. This figure is presented as an educational correlate rather than proof of frame decoupling in a constrained self-expanding transcatheter heart valve inflow actually leading to stent-frame overexpansion at the coaptation level. Adapted with permission from Midha PA et al, JACC Cardiovasc Interv. 2016;9:1618–1628 The 26-mm Evolut THV was intentionally selected because the maximal diameter of the severely restricted geometric orifice was 22.5 mm, within the 20 to 23 mm annular diameter range listed for the 26-mm Evolut THV platform. Thus, the choice reflected an ex vivo constraint-orifice-based stress-test strategy rather than a conventional clinical annular-sizing recommendation. By conventional angio-CT annular dimensions, the device was relatively undersized vs the annulus, ICD, and STJ; however, it was selected to interrogate how a self-expanding supra-annular nitinol frame behaves when exposed to an unmodified rigid calcified bicuspid orifice. This interpretation is consistent with contemporary BAV sizing concepts, which emphasize that annular sizing alone may be insufficient in BAV. The BAVARD concept supports incorporating annular and ICD measurements, particularly in tapered configurations.5 Similarly, the level of implantation at the raphe supra-annular sizing approach highlights that in raphe-type BAV, the most relevant constraint may occur at the raphe (supra-annular) level rather than at the annulus.6 In clinical practice, balloon predilatation is often used in heavily calcified BAV to prepare the landing zone and facilitate device expansion. In our model, no balloon predilatation or postdilatation was performed, intentionally preserving the native rigid calcified constraint. Therefore, the deployment strategy should be understood as a mechanistic stress test, not as an optimized clinical transcatheter aortic valve replacement technique. The main educational value of this report is the direct clinical angio-CT–specimen–device–IVUS correlation. CT remains the reference standard for postprocedural assessment of THV geometry, but it is not available during deployment. Angiography was not performed in this ex vivo bench model; however, the findings address a broader limitation of projection-based procedural assessment. The observed frame geometry was highly nonuniform: Severe inflow constraint coexisted with relative preservation of the supra-annular nadir and coaptation levels. Such segmental deformation cannot be reliably inferred from external inspection or from a single projected silhouette. IVUS, by contrast, provided a true short-axis tomographic perspective at matched frame levels and allowed direct measurement of Dmin, Dmax, CSA, ellipticity, and segmental % expansion. Importantly, IVUS-derived stent-frame dimensions corresponded closely with direct ex vivo caliper measurements, supporting the accuracy of IVUS for matched-level assessment of actual THV frame geometry in this model. These observations support the concept that real-time tomographic assessment during THV implantation could enable a more detailed understanding of deployment mechanics and may provide the imaging basis for future implantation and optimization strategies guided by actual frame geometry rather than projectional appearance (angiography) alone. However, this single ex vivo model lacked physiologic flow, transvalvular gradients, leaflet motion under pulsatile loading, leaflet thrombosis assessment, and clinical outcomes. Therefore, the present data should not be used to define thresholds for predilatation, postdilatation, valve selection, or acceptance of final THV geometry. Future in vivo studies combining IVUS-derived geometry with hemodynamics, angio-CT, and follow-up outcomes are required. Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose. Footnotes The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center. References